| Application Number | Priority Date | Filing Date | Title | 
|---|---|---|---|
| GBGB0820819.1AGB0820819D0 (en) | 2008-11-13 | 2008-11-13 | Pharmaceutical compounds | 
| PCT/GB2009/002662WO2010055304A2 (en) | 2008-11-13 | 2009-11-13 | Pharmaceutical compounds | 
| Application Number | Priority Date | Filing Date | Title | 
|---|---|---|---|
| GBGB0820819.1AGB0820819D0 (en) | 2008-11-13 | 2008-11-13 | Pharmaceutical compounds | 
| Publication Number | Publication Date | 
|---|---|
| GB0820819D0true GB0820819D0 (en) | 2008-12-24 | 
| Application Number | Title | Priority Date | Filing Date | 
|---|---|---|---|
| GBGB0820819.1ACeasedGB0820819D0 (en) | 2008-11-13 | 2008-11-13 | Pharmaceutical compounds | 
| Country | Link | 
|---|---|
| GB (1) | GB0820819D0 (en) | 
| WO (1) | WO2010055304A2 (en) | 
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| EP2250160B1 (en) | 2008-01-25 | 2015-11-11 | Millennium Pharmaceuticals, Inc. | Thiophenes and their use as phosphatidylinositol 3-kinase (pi3k) inhibitors | 
| US9090601B2 (en) | 2009-01-30 | 2015-07-28 | Millennium Pharmaceuticals, Inc. | Thiazole derivatives | 
| WO2010090716A1 (en) | 2009-01-30 | 2010-08-12 | Millennium Pharmaceuticals, Inc. | Heteroaryls and their use as pi3k inhibitors | 
| US8796314B2 (en) | 2009-01-30 | 2014-08-05 | Millennium Pharmaceuticals, Inc. | Heteroaryls and uses thereof | 
| US9062038B2 (en) | 2010-08-11 | 2015-06-23 | Millennium Pharmaceuticals, Inc. | Heteroaryls and uses thereof | 
| JP2013533318A (en) | 2010-08-11 | 2013-08-22 | ミレニアム ファーマシューティカルズ, インコーポレイテッド | Heteroaryl and uses thereof | 
| KR20130098334A (en) | 2010-08-11 | 2013-09-04 | 밀레니엄 파머슈티컬스 인코퍼레이티드 | Heteroaryls and uses thereof | 
| US8765746B2 (en) | 2010-10-13 | 2014-07-01 | Millennium Pharmaceuticals, Inc. | Heteroaryls and uses thereof | 
| WO2012075393A2 (en)* | 2010-12-02 | 2012-06-07 | President And Fellows Of Harvard College | Activators of proteasomal degradation and uses thereof | 
| GB201202027D0 (en)* | 2012-02-06 | 2012-03-21 | Sareum Ltd | Pharmaceutical compounds | 
| EP3040336B1 (en) | 2012-03-02 | 2020-04-08 | Sareum Limited | Compounds for use in treating tyk2 kinase mediated conditions | 
| JP6348492B2 (en)* | 2012-08-10 | 2018-06-27 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Heteroaromatic compounds as breton-type tyrosine kinase (BTK) inhibitors | 
| CN103848810A (en)* | 2012-11-30 | 2014-06-11 | 北京赛林泰医药技术有限公司 | Bruton's tyrosine kinases inhibitor | 
| WO2014151620A1 (en) | 2013-03-14 | 2014-09-25 | Boehringer Ingelheim International Gmbh | 5-thiazolecarboxamide dervatives and their use as btk inhibitors | 
| WO2014152114A1 (en) | 2013-03-15 | 2014-09-25 | Boehringer Ingelheim International Gmbh | Heteroaromatic compounds as btk inhibitors | 
| KR102191084B1 (en)* | 2013-09-03 | 2020-12-15 | 사름 리미티드 | Pharmaceutical compounds | 
| SI3052476T1 (en) | 2013-09-30 | 2020-12-31 | Guangzhou Innocare Pharma Tech Co., Ltd. | Substituted nicotinimide inhibitors of btk and their preparation and use in the treatment of cancer, inflammation and autoimmune disease | 
| US9828364B2 (en) | 2014-01-29 | 2017-11-28 | Boehringer Ingelheim International Gmbh | Pyrazole compounds as BTK inhibitors | 
| WO2016077163A1 (en)* | 2014-11-11 | 2016-05-19 | Musc Foundation For Research Development | Histone deacetylase inhibitors and uses thereof | 
| CN108368086B (en) | 2015-12-16 | 2021-01-08 | 勃林格殷格翰国际有限公司 | Dipyrazolyl derivatives useful in the treatment of autoimmune diseases | 
| EP3402789B1 (en) | 2016-01-13 | 2020-03-18 | Boehringer Ingelheim International Gmbh | Isoquinolones as btk inhibitors | 
| GB201617871D0 (en) | 2016-10-21 | 2016-12-07 | Sareum Limited | Pharmaceutical compounds | 
| GB201816369D0 (en) | 2018-10-08 | 2018-11-28 | Sareum Ltd | Pharmaceutical compounds | 
| KR20220002488A (en) | 2019-04-30 | 2022-01-06 | 셀진 코포레이션 | Combination therapy comprising apremilast and a TYK2 inhibitor | 
| GB202005114D0 (en) | 2020-04-07 | 2020-05-20 | Sareum Ltd | Crystalline Forms of a Pharmaceutical Compound | 
| US20240287052A1 (en)* | 2021-06-01 | 2024-08-29 | Azcuris Co., Ltd. | Novel oxazole derivative and pharmaceutical composition for preventing or treating allergic diseases comprising the same | 
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| JPS61155456A (en) | 1984-12-27 | 1986-07-15 | Fujikura Rubber Ltd | Electromagnetic wave shielding composition | 
| JPH0753716B2 (en) | 1986-07-02 | 1995-06-07 | 吉富製薬株式会社 | Imidazol carboxamide derivative | 
| WO2002000649A1 (en) | 2000-06-28 | 2002-01-03 | Astrazeneca Ab | Substituted quinazoline derivatives and their use as inhibitors | 
| US6884889B2 (en) | 2002-03-25 | 2005-04-26 | Bristol-Myers Squibb Co. | Processes for the preparation of antiviral 7-azaindole derivatives | 
| CA2491895C (en) | 2002-07-09 | 2011-01-18 | Vertex Pharmaceuticals Incorporated | Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases | 
| EP1620406A2 (en)* | 2003-05-08 | 2006-02-01 | Astellas Pharma Inc. | 1,2-diarylimidazoles useful as inhibitors of cox | 
| GB0321648D0 (en) | 2003-09-16 | 2003-10-15 | Astrazeneca Ab | Quinazoline derivatives | 
| EP1684750B1 (en) | 2003-10-23 | 2010-04-28 | AB Science | 2-aminoaryloxazole compounds as tyrosine kinase inhibitors | 
| JP2008517060A (en) | 2004-10-19 | 2008-05-22 | エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド | CRF receptor antagonist and process for producing the same | 
| GB0504753D0 (en) | 2005-03-08 | 2005-04-13 | Astrazeneca Ab | Chemical compounds | 
| JPWO2007043401A1 (en) | 2005-10-07 | 2009-04-16 | キッセイ薬品工業株式会社 | Nitrogen-containing heterocyclic compound and pharmaceutical composition containing the same | 
| DE602007009085D1 (en) | 2006-05-12 | 2010-10-21 | Ab Science | NEW PROCEDURE FOR SYNTHESIS OF 2-AMINO-OXAZO COMPOUNDS | 
| WO2008024980A2 (en) | 2006-08-24 | 2008-02-28 | Serenex, Inc. | Pyrrole, thiophene, furan, imidazole, oxazole, and thiazole derivatives | 
| GB0709031D0 (en)* | 2007-05-10 | 2007-06-20 | Sareum Ltd | Pharmaceutical compounds | 
| Publication number | Publication date | 
|---|---|
| WO2010055304A3 (en) | 2010-07-08 | 
| WO2010055304A2 (en) | 2010-05-20 | 
| Publication | Publication Date | Title | 
|---|---|---|
| ZA201104336B (en) | Pharmaceutical compounds | |
| GB0816372D0 (en) | Pharmaceutical compounds | |
| GB0820819D0 (en) | Pharmaceutical compounds | |
| GB0801416D0 (en) | Pharmaceutical compounds | |
| IL237392A0 (en) | Pharmaceutical combination | |
| GB0709031D0 (en) | Pharmaceutical compounds | |
| IL201366A0 (en) | Pharmaceutical compounds | |
| GB0721095D0 (en) | Pharmaceutical compounds | |
| GB0816371D0 (en) | Pharmaceutical compounds | |
| GB0707087D0 (en) | Pharmaceutical compounds | |
| GB0810615D0 (en) | Novel pharmaceutical | |
| GB0704932D0 (en) | Pharmaceutical compounds | |
| GB0725214D0 (en) | Pharmaceutical compounds | |
| GB0812969D0 (en) | Pharmaceutical compounds | |
| PL2271618T3 (en) | Pharmaceutical compounds | |
| GB0816370D0 (en) | Pharmaceutical compounds | |
| GB0721669D0 (en) | Pharmaceutical compounds | |
| IL208953A0 (en) | Pharmaceutical combination | |
| GB0810857D0 (en) | Pharmaceutical compounds | |
| GB0810617D0 (en) | Novel pharmaceutical | |
| HU0800414D0 (en) | Pharmaceutical combination | |
| GB0817006D0 (en) | Pharmaceutical compounds | |
| GB0805300D0 (en) | Pharmaceutical compounds | |
| GB0802252D0 (en) | Pharmaceutical compounds | |
| GB0807502D0 (en) | Pharmaceutical compounds | 
| Date | Code | Title | Description | 
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |